Common Contracts

ASSET PURCHASE AGREEMENT

Asset Purchase Agreement • March 21st, 2019 • Delaware

• Contract Type
  Asset Purchase Agreement
• Filed
  March 21st, 2019
• Jurisdiction
  Delaware

This Asset Purchase Agreement (this “Agreement”), dated as of March 20, 2019, is entered into among MabVax Therapeutics Holdings, Inc. (“MabVax Holdings”), a Delaware corporation, MabVax Therapeutics, Inc. (“MabVax Therapeutics”, together with MabMax Holdings, the “Sellers”, and each being a “Seller”), a Delaware corporation and a wholly-owned subsidiary of MabVax Holdings, and BioNTech Research and Development, Inc. (“Buyer”), a Delaware corporation.